Selected research
Industry Research
Oral and Topical Anaesthetics Industry Research Report 2026
Market perspective
The global Oral and Topical Anaesthetics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oral and Topical Anaesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oral and Topical Anaesthetics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oral and Topical Anaesthetics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oral and Topical Anaesthetics include Johnson & Johnson, Roche, Fresenius, AbbVie, Septodont, Pfizer (Hospira), Hikma Pharmaceuticals, Gilead Sciences and Dentsply Sirona, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oral and Topical Anaesthetics market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oral and Topical Anaesthetics Market by Company
Johnson & Johnson
Roche
Fresenius
AbbVie
Septodont
Pfizer (Hospira)
Hikma Pharmaceuticals
Gilead Sciences
Dentsply Sirona
Baxter International
Aspen Pharmacare
Abbott Laboratories
Oral and Topical Anaesthetics Segment by Type
Aqueous
Non-aqueous
Oral and Topical Anaesthetics Segment by Application
Dental Clinics
Pharmacies and Drug Stores
Hospitals
Oral and Topical Anaesthetics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral and Topical Anaesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral and Topical Anaesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral and Topical Anaesthetics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral and Topical Anaesthetics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral and Topical Anaesthetics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral and Topical Anaesthetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aqueous
- Non-aqueous
Applications
- Dental Clinics
- Pharmacies and Drug Stores
- Hospitals
Companies covered
- Johnson & Johnson
- Roche
- Fresenius
- AbbVie
- Septodont
- Pfizer (Hospira)
- Hikma Pharmaceuticals
- Gilead Sciences
- Dentsply Sirona
- Baxter International
- Aspen Pharmacare
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oral and Topical Anaesthetics Market Size (2021-2032)
- 2.2.2 Global Oral and Topical Anaesthetics Sales (2021-2032)
- 2.2.3 Global Oral and Topical Anaesthetics Market Average Price (2021-2032)
- 2.3 Oral and Topical Anaesthetics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Aqueous
- 2.3.3 Non-aqueous
- 2.4 Oral and Topical Anaesthetics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dental Clinics
- 2.4.3 Pharmacies and Drug Stores
- 2.4.4 Hospitals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oral and Topical Anaesthetics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oral and Topical Anaesthetics Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Oral and Topical Anaesthetics Revenue of Manufacturers (2021-2026)
- 3.4 Global Oral and Topical Anaesthetics Average Price by Manufacturers (2021-2026)
- 3.5 Global Oral and Topical Anaesthetics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oral and Topical Anaesthetics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oral and Topical Anaesthetics, Product Type & Application
- 3.8 Global Manufacturers of Oral and Topical Anaesthetics, Established Date
- 3.9 Global Oral and Topical Anaesthetics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Oral and Topical Anaesthetics Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Roche
- 4.2.1 Roche Company Information
- 4.2.2 Roche Business Overview
- 4.2.3 Roche Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Roche Oral and Topical Anaesthetics Product Portfolio
- 4.2.5 Roche Recent Developments
- 4.3 Fresenius
- 4.3.1 Fresenius Company Information
- 4.3.2 Fresenius Business Overview
- 4.3.3 Fresenius Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fresenius Oral and Topical Anaesthetics Product Portfolio
- 4.3.5 Fresenius Recent Developments
- 4.4 AbbVie
- 4.4.1 AbbVie Company Information
- 4.4.2 AbbVie Business Overview
- 4.4.3 AbbVie Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AbbVie Oral and Topical Anaesthetics Product Portfolio
- 4.4.5 AbbVie Recent Developments
- 4.5 Septodont
- 4.5.1 Septodont Company Information
- 4.5.2 Septodont Business Overview
- 4.5.3 Septodont Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Septodont Oral and Topical Anaesthetics Product Portfolio
- 4.5.5 Septodont Recent Developments
- 4.6 Pfizer (Hospira)
- 4.6.1 Pfizer (Hospira) Company Information
- 4.6.2 Pfizer (Hospira) Business Overview
- 4.6.3 Pfizer (Hospira) Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer (Hospira) Oral and Topical Anaesthetics Product Portfolio
- 4.6.5 Pfizer (Hospira) Recent Developments
- 4.7 Hikma Pharmaceuticals
- 4.7.1 Hikma Pharmaceuticals Company Information
- 4.7.2 Hikma Pharmaceuticals Business Overview
- 4.7.3 Hikma Pharmaceuticals Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hikma Pharmaceuticals Oral and Topical Anaesthetics Product Portfolio
- 4.7.5 Hikma Pharmaceuticals Recent Developments
- 4.8 Gilead Sciences
- 4.8.1 Gilead Sciences Company Information
- 4.8.2 Gilead Sciences Business Overview
- 4.8.3 Gilead Sciences Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Gilead Sciences Oral and Topical Anaesthetics Product Portfolio
- 4.8.5 Gilead Sciences Recent Developments
- 4.9 Dentsply Sirona
- 4.9.1 Dentsply Sirona Company Information
- 4.9.2 Dentsply Sirona Business Overview
- 4.9.3 Dentsply Sirona Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dentsply Sirona Oral and Topical Anaesthetics Product Portfolio
- 4.9.5 Dentsply Sirona Recent Developments
- 4.10 Baxter International
- 4.10.1 Baxter International Company Information
- 4.10.2 Baxter International Business Overview
- 4.10.3 Baxter International Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Baxter International Oral and Topical Anaesthetics Product Portfolio
- 4.10.5 Baxter International Recent Developments
- 4.11 Aspen Pharmacare
- 4.11.1 Aspen Pharmacare Company Information
- 4.11.2 Aspen Pharmacare Business Overview
- 4.11.3 Aspen Pharmacare Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Aspen Pharmacare Oral and Topical Anaesthetics Product Portfolio
- 4.11.5 Aspen Pharmacare Recent Developments
- 4.12 Abbott Laboratories
- 4.12.1 Abbott Laboratories Company Information
- 4.12.2 Abbott Laboratories Business Overview
- 4.12.3 Abbott Laboratories Oral and Topical Anaesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Abbott Laboratories Oral and Topical Anaesthetics Product Portfolio
- 4.12.5 Abbott Laboratories Recent Developments
5 Global Oral and Topical Anaesthetics Market Scenario by Region
- 5.1 Global Oral and Topical Anaesthetics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oral and Topical Anaesthetics Sales by Region: 2021-2032
- 5.2.1 Global Oral and Topical Anaesthetics Sales by Region: 2021-2026
- 5.2.2 Global Oral and Topical Anaesthetics Sales by Region: 2027-2032
- 5.3 Global Oral and Topical Anaesthetics Revenue by Region: 2021-2032
- 5.3.1 Global Oral and Topical Anaesthetics Revenue by Region: 2021-2026
- 5.3.2 Global Oral and Topical Anaesthetics Revenue by Region: 2027-2032
- 5.4 North America Oral and Topical Anaesthetics Market Facts & Figures by Country
- 5.4.1 North America Oral and Topical Anaesthetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oral and Topical Anaesthetics Sales by Country (2021-2032)
- 5.4.3 North America Oral and Topical Anaesthetics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Oral and Topical Anaesthetics Market Facts & Figures by Country
- 5.5.1 Europe Oral and Topical Anaesthetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oral and Topical Anaesthetics Sales by Country (2021-2032)
- 5.5.3 Europe Oral and Topical Anaesthetics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Oral and Topical Anaesthetics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oral and Topical Anaesthetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oral and Topical Anaesthetics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oral and Topical Anaesthetics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oral and Topical Anaesthetics Market Facts & Figures by Country
- 5.7.1 South America Oral and Topical Anaesthetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oral and Topical Anaesthetics Sales by Country (2021-2032)
- 5.7.3 South America Oral and Topical Anaesthetics Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Oral and Topical Anaesthetics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oral and Topical Anaesthetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oral and Topical Anaesthetics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oral and Topical Anaesthetics Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Oral and Topical Anaesthetics Sales by Type (2021-2032)
- 6.1.1 Global Oral and Topical Anaesthetics Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Oral and Topical Anaesthetics Sales Market Share by Type (2021-2032)
- 6.2 Global Oral and Topical Anaesthetics Revenue by Type (2021-2032)
- 6.2.1 Global Oral and Topical Anaesthetics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oral and Topical Anaesthetics Revenue Market Share by Type (2021-2032)
- 6.3 Global Oral and Topical Anaesthetics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oral and Topical Anaesthetics Sales by Application (2021-2032)
- 7.1.1 Global Oral and Topical Anaesthetics Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Oral and Topical Anaesthetics Sales Market Share by Application (2021-2032)
- 7.2 Global Oral and Topical Anaesthetics Revenue by Application (2021-2032)
- 7.2.1 Global Oral and Topical Anaesthetics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oral and Topical Anaesthetics Revenue Market Share by Application (2021-2032)
- 7.3 Global Oral and Topical Anaesthetics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oral and Topical Anaesthetics Value Chain Analysis
- 8.1.1 Oral and Topical Anaesthetics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oral and Topical Anaesthetics Production Mode & Process
- 8.2 Oral and Topical Anaesthetics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oral and Topical Anaesthetics Distributors
- 8.2.3 Oral and Topical Anaesthetics Customers
9 Global Oral and Topical Anaesthetics Analyzing Market Dynamics
- 9.1 Oral and Topical Anaesthetics Industry Trends
- 9.2 Oral and Topical Anaesthetics Industry Drivers
- 9.3 Oral and Topical Anaesthetics Industry Opportunities and Challenges
- 9.4 Oral and Topical Anaesthetics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst